Biocryst Pharmaceuticals Inc

Mid-Cap Stocks Stocks Under $10 Biotech Stocks Healthcare Stocks

$8.68

-0.02 (-0.23%)

As of Sep 20, 10:10 PM ET ·

Analyst Consensus

Strong Buy

Analysts

High

Coverage

Buy 15 88%

Hold 2 12%

Sell 0 0%

Price Target

Analyst Price Target +661.8% upside

Low Target $46.17

Average Target $66.12

High Target $78.89

Current Price $8.68

Current
$8.68

Target
$66.12

$46.17 $66.12 avg $78.89

Scenario Analysis

Bear Case

$46.17

431.9%

Low target

Base Case

$66.12

+661.8%

Avg target

Bull Case

$78.89

+808.9%

High target

Risk/Reward

1.9x

Balanced

Price in Context

52-Week High

$11.22

-22.6% from high

52-Week Low

$6.00

+44.7% from low

Target vs 52W High

$66.12

+489.3% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-2.8%
AMGN Amgen Inc	Hold	43	47%	$190.87	-53.0%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+141.2%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	36	81%	$438.34	-14.9%
REGN Regeneron Pharmaceuticals	Buy	38	68%	$76.80	-90.4%
MRNA Moderna Inc	Hold	30	37%	$149.45	-18.2%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-63.8%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-40.3%